| PERIOD ENDING | 31-Dec-08 | | Total Revenue |
-
| | Cost of Revenue |
-
| | | Gross Profit |
-
| | | Operating Expenses | | Research Development | 259 | | Selling General and Administrative | 1,262 | | Non Recurring |
-
| | Others | 13 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (1,534) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28 | | Earnings Before Interest And Taxes | (1,506) | | Interest Expense |
-
| | Income Before Tax | (1,506) | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | (1,506) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (1,506) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($1,506) |
|
1.52% Nasdaq 0.00%
Income Statement
